News in multiple sclerosis: Remyelination as a therapeutic target
Med Clin (Barc). 2017 Apr 21;148(8):377-380.
doi: 10.1016/j.medcli.2016.10.021.
Epub 2016 Dec 4.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria San Carlos (idiSSC), Madrid, España. Electronic address: [email protected].
- 2 Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria San Carlos (idiSSC), Madrid, España.
No abstract available
MeSH terms
-
Humans
-
Immunologic Factors / pharmacology
-
Immunologic Factors / therapeutic use*
-
Multiple Sclerosis / diagnosis
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / physiopathology
-
Peripheral Nervous System Agents / pharmacology
-
Peripheral Nervous System Agents / therapeutic use*
-
Remyelination / drug effects*
Substances
-
Immunologic Factors
-
Peripheral Nervous System Agents